Economic evaluation of the OSAC randomised controlled trial: oral corticosteroids for non-asthmatic adults with acute lower respiratory tract infection in primary care

OBJECTIVE: To estimate the costs and outcomes associated with treating non-asthmatic adults (nor suffering from other lung-disease) presenting to primary care with acute lower respiratory tract infection (ALRTI) with oral corticosteroids compared with placebo. DESIGN: Cost-consequence analysis along...

Descripción completa

Detalles Bibliográficos
Autores principales: Moure-Fernandez, Aida, Hollinghurst, Sandra, Carroll, Fran E, Downing, Harriet, Young, Grace, Brookes, Sara, May, Margaret, El-Gohary, Magdy, Harnden, Anthony, Kendrick, Denise, Lafond, Natasher, Little, Paul, Moore, Michael, Orton, Elizabeth, Thompson, Matthew, Timmins, David, Wang, Kay, Hay, Alastair D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045138/
https://www.ncbi.nlm.nih.gov/pubmed/32075830
http://dx.doi.org/10.1136/bmjopen-2019-033567

Ejemplares similares

Ejemplares similares